Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Generate:Biomedicines raised ...

File and folder security is crucial in this day and age. There are apps you can use to heighten the security of your files. These apps are free and available for desktop and mobile devices. The need ...

AI chatbots for business have shifted from simple support tools to frontline revenue engines that engage visitors the moment they land on a site. By combining natural language processing with ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

Has AI coding reached a tipping point? That seems to be the case for Spotify at least, which shared this week during its fourth-quarter earnings call that the best developers at the company “have not ...

Amid a push toward AI agents, with both Anthropic and OpenAI shipping multi-agent tools this week, Anthropic is more than ready to show off some of its more daring AI coding experiments. But as usual ...

Claude Opus 4.6 AI agents built a Rust-based C compiler in two weeks The compiler passed 99 percent of GCC torture tests and compiled the game Doom Anthropic's AI can handle complex software ...